Breaking News

Asymchem Completes Construction of Two New Production Sites

Available batch capacity now doubled to meet growing demands.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Asymchem Laboratories (Tianjin) Co., Ltd., a contract development and manufacturing organization (CDMO) serving the global pharmaceutical and biotech industry, has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500 cubic meters of batch capacity to meet demands for upcoming commercialization projects. In addition, an active pharmaceutical ingredient (API) building expansion was completed at the company’s Tianjin site, with an e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters